292 related articles for article (PubMed ID: 27221467)
1. MicroRNA-146a suppresses ROCK1 allowing hyperphosphorylation of tau in Alzheimer's disease.
Wang G; Huang Y; Wang LL; Zhang YF; Xu J; Zhou Y; Lourenco GF; Zhang B; Wang Y; Ren RJ; Halliday GM; Chen SD
Sci Rep; 2016 May; 6():26697. PubMed ID: 27221467
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-125b induces tau hyperphosphorylation and cognitive deficits in Alzheimer's disease.
Banzhaf-Strathmann J; Benito E; May S; Arzberger T; Tahirovic S; Kretzschmar H; Fischer A; Edbauer D
EMBO J; 2014 Aug; 33(15):1667-80. PubMed ID: 25001178
[TBL] [Abstract][Full Text] [Related]
3. miR-200c suppression increases tau hyperphosphorylation by targeting 14-3-3γ in early stage of 5xFAD mouse model of Alzheimer's disease.
Park H; Lee YB; Chang KA
Int J Biol Sci; 2022; 18(5):2220-2234. PubMed ID: 35342350
[No Abstract] [Full Text] [Related]
4. miR-106b inhibits tau phosphorylation at Tyr18 by targeting Fyn in a model of Alzheimer's disease.
Liu W; Zhao J; Lu G
Biochem Biophys Res Commun; 2016 Sep; 478(2):852-7. PubMed ID: 27520374
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-922 promotes tau phosphorylation by downregulating ubiquitin carboxy-terminal hydrolase L1 (UCHL1) expression in the pathogenesis of Alzheimer's disease.
Zhao ZB; Wu L; Xiong R; Wang LL; Zhang B; Wang C; Li H; Liang L; Chen SD
Neuroscience; 2014 Sep; 275():232-7. PubMed ID: 24950120
[TBL] [Abstract][Full Text] [Related]
6. Rho-associated protein kinase 1 (ROCK1) is increased in Alzheimer's disease and ROCK1 depletion reduces amyloid-β levels in brain.
Henderson BW; Gentry EG; Rush T; Troncoso JC; Thambisetty M; Montine TJ; Herskowitz JH
J Neurochem; 2016 Aug; 138(4):525-31. PubMed ID: 27246255
[TBL] [Abstract][Full Text] [Related]
7. Knockdown of long non-coding RNA TUG1 depresses apoptosis of hippocampal neurons in Alzheimer's disease by elevating microRNA-15a and repressing ROCK1 expression.
Li X; Wang SW; Li XL; Yu FY; Cong HM
Inflamm Res; 2020 Sep; 69(9):897-910. PubMed ID: 32577774
[TBL] [Abstract][Full Text] [Related]
8. O-GlcNAcylation regulates phosphorylation of tau: a mechanism involved in Alzheimer's disease.
Liu F; Iqbal K; Grundke-Iqbal I; Hart GW; Gong CX
Proc Natl Acad Sci U S A; 2004 Jul; 101(29):10804-9. PubMed ID: 15249677
[TBL] [Abstract][Full Text] [Related]
9. The novel calpain inhibitor A-705253 prevents stress-induced tau hyperphosphorylation in vitro and in vivo.
Nikkel AL; Martino B; Markosyan S; Brederson JD; Medeiros R; Moeller A; Bitner RS
Neuropharmacology; 2012 Sep; 63(4):606-12. PubMed ID: 22613839
[TBL] [Abstract][Full Text] [Related]
10. Hyperphosphorylation of microtubule-associated protein tau: a promising therapeutic target for Alzheimer disease.
Gong CX; Iqbal K
Curr Med Chem; 2008; 15(23):2321-8. PubMed ID: 18855662
[TBL] [Abstract][Full Text] [Related]
11. Alterations in glucose metabolism induce hypothermia leading to tau hyperphosphorylation through differential inhibition of kinase and phosphatase activities: implications for Alzheimer's disease.
Planel E; Miyasaka T; Launey T; Chui DH; Tanemura K; Sato S; Murayama O; Ishiguro K; Tatebayashi Y; Takashima A
J Neurosci; 2004 Mar; 24(10):2401-11. PubMed ID: 15014115
[TBL] [Abstract][Full Text] [Related]
12. Alzheimer's disease-type neuronal tau hyperphosphorylation induced by A beta oligomers.
De Felice FG; Wu D; Lambert MP; Fernandez SJ; Velasco PT; Lacor PN; Bigio EH; Jerecic J; Acton PJ; Shughrue PJ; Chen-Dodson E; Kinney GG; Klein WL
Neurobiol Aging; 2008 Sep; 29(9):1334-47. PubMed ID: 17403556
[TBL] [Abstract][Full Text] [Related]
13. UBE4B, a microRNA-9 target gene, promotes autophagy-mediated Tau degradation.
Subramanian M; Hyeon SJ; Das T; Suh YS; Kim YK; Lee JS; Song EJ; Ryu H; Yu K
Nat Commun; 2021 Jun; 12(1):3291. PubMed ID: 34078905
[TBL] [Abstract][Full Text] [Related]
14. Reduced miR-512 and the Elevated Expression of Its Targets cFLIP and MCL1 Localize to Neurons With Hyperphosphorylated Tau Protein in Alzheimer Disease.
Mezache L; Mikhail M; Garofalo M; Nuovo GJ
Appl Immunohistochem Mol Morphol; 2015 Oct; 23(9):615-23. PubMed ID: 26258756
[TBL] [Abstract][Full Text] [Related]
15. Phosphorylation of tau antagonizes apoptosis by stabilizing beta-catenin, a mechanism involved in Alzheimer's neurodegeneration.
Li HL; Wang HH; Liu SJ; Deng YQ; Zhang YJ; Tian Q; Wang XC; Chen XQ; Yang Y; Zhang JY; Wang Q; Xu H; Liao FF; Wang JZ
Proc Natl Acad Sci U S A; 2007 Feb; 104(9):3591-6. PubMed ID: 17360687
[TBL] [Abstract][Full Text] [Related]
16. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.
Padmanabhan J; Levy M; Dickson DW; Potter H
Brain; 2006 Nov; 129(Pt 11):3020-34. PubMed ID: 16987932
[TBL] [Abstract][Full Text] [Related]
17. Tau pathology in Alzheimer disease and other tauopathies.
Iqbal K; Alonso Adel C; Chen S; Chohan MO; El-Akkad E; Gong CX; Khatoon S; Li B; Liu F; Rahman A; Tanimukai H; Grundke-Iqbal I
Biochim Biophys Acta; 2005 Jan; 1739(2-3):198-210. PubMed ID: 15615638
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-146a regulates the expression of the Aβ1-42 protein in Alzheimer's disease.
Huang P; Xu M; He YX
Eur Rev Med Pharmacol Sci; 2021 Feb; 25(4):2003-2012. PubMed ID: 33660812
[TBL] [Abstract][Full Text] [Related]
19. JNK plays a key role in tau hyperphosphorylation in Alzheimer's disease models.
Ploia C; Antoniou X; Sclip A; Grande V; Cardinetti D; Colombo A; Canu N; Benussi L; Ghidoni R; Forloni G; Borsello T
J Alzheimers Dis; 2011; 26(2):315-29. PubMed ID: 21628793
[TBL] [Abstract][Full Text] [Related]
20. The Ambiguous Relationship of Oxidative Stress, Tau Hyperphosphorylation, and Autophagy Dysfunction in Alzheimer's Disease.
Liu Z; Li T; Li P; Wei N; Zhao Z; Liang H; Ji X; Chen W; Xue M; Wei J
Oxid Med Cell Longev; 2015; 2015():352723. PubMed ID: 26171115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
